Scarica l'app Stockscreener
128.90
0.28%
0.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
Abbott, Unity, Lowe’s, Vertiv, Roblox: Insider Moves Unveiled - TipRanks
How Analyst Views on Abbott Are Evolving as Its Growth Story Faces New Twists - Yahoo Finance
Aug Momentum: Is Abbott Laboratories stock a smart buy before Fed meetingQuarterly Portfolio Review & Free Risk Controlled Daily Trade Plans - moha.gov.vn
Abbott faces FLSA collective over alleged overtime pay calculations - HRD America
How Abbott’s Medical Device Advances Are Shaping Its 2025 Valuation Debate - simplywall.st
Abbott Accused Of Miscalculating Workers' Overtime - Law360
Assessing Abbott Laboratories (ABT) Valuation Following Steady 2024 Gains and Analyst Growth Projections - simplywall.st
Is Abbott Laboratories Stock Underperforming the S&P 500? - Barchart.com
Abbott Laboratories (ABT) Valuation in Focus After Renewed Trading Momentum - Yahoo Finance
Top Abbott Exec Cashes In on Stock Sale! - TipRanks
Insider Sell: Eric Shroff Sells Shares of Abbott Laboratories (A - GuruFocus
Abbott’s $23B Bet on Exact Sciences: Bold Move or Risky Gamble? - MedCity News
Abbott Laboratories SVP Shroff sells $203k in stock - Investing.com India
Abbott shares safety concerns with millions of CGM sensors—7 deaths reported - Cardiovascular Business
Abbott to replace glucose monitors after deaths possibly linked to false readings - Crain's Chicago Business
Abbott Laboratories Limited Appoints Brian William Jordan as A New Director, Effective November 25, 2025 - MarketScreener
Exact Sciences stock rating downgraded to Hold by TD Cowen following Abbott deal - Investing.com
Canaccord Genuity downgrades Exact Sciences stock to Hold after Abbott deal - Investing.com India
Abbott issues US device correction for some glucose monitors over faulty readings risk - WTVB
Abbott's Exact Sciences Acquisition Signals Maturation of Single-Site Specialty Dx Space - 360Dx
Abbott Laboratories Issues Correction on 3 Million Glucose Sensors Over Possible Faulty Readings - NTD News
Abbott mum on malfunction behind Freestyle Libre 3 recall - BioWorld MedTech
Abbott issues correction for millions of glucose sensors - MedTech Dive
Key facts: Abbott Labs to acquire Exact Sciences for $23 billion; recalls FreeStyle Libre 3 sensors - TradingView
Abbott issues medical device correction for some glucose monitors in U.S. - MarketScreener
Abbott is buying Exact Sciences. Here’s why - Modern Healthcare
Jefferies cuts Exact Sciences to 'hold' after Abbott acquisition - TradingView
Is Weakness In Abbott Laboratories (NYSE:ABT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - Yahoo Finance
Jefferies downgrades Exact Sciences stock to Hold after Abbott acquisition - Investing.com
Jim Cramer on Abbott: “I Think It’s a Terrific Time to Do Some Buying” - MSN
Jim Cramer on Abbott: "I Think It's a Terrific Time to Do Some Buying" - Finviz
Exact Sciences (EXAS) Shares Surge on Abbott Acquisition Deal - GuruFocus
Notable healthcare headlines for the week: Abbott, Medtronic, Merck and J&J in focus - MSN
Abbott’s (ABT) Exact Sciences Deal is “Very, Very Important,” Says Jim Cramer - MSN
Abbott's (ABT) Exact Sciences Deal is "Very, Very Important," Says Jim Cramer - Finviz
Exact Sciences Catapults, Breaking Out, On Rumored Abbott Laboratories - MSN
AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know - MSN
Abbott acquires cancer diagnostic company Exact Sciences for $21B - HealthExec
William Blair Remains a Buy on Abbott Laboratories (ABT) - The Globe and Mail
ABTAbbott Laboratories Stock Price and Quote - Finviz
Abbott Laboratories Stock Price Forecast: Where Analysts See the Stock Going by 2027 - TIKR.com
Abbott Labs stock to acquire Exact Sciences for $21 billion By Investing.com - Investing.com Nigeria
Deal Dispatch: Abbott, TPG And Lonza Make Major Moves, M&M Custard And New Fortress Energy Struggle - Benzinga
Abbott Laboratories: Not Passing The Test After Buying Test Maker Exact Sciences (ABT) - Seeking Alpha
Abbott to acquire Exact Sciences in $21 billion deal, aiming to lead in fast-growing cancer diagnostics market - Medical Economics
Abbott’s $21B Exact Sciences buy reveals future strategy - MedTech Dive
Abbott Laboratories to acquire Exact Sciences for $23B in largest-ever diagnostics deal - The Business Journals
Abbott Laboratories Acquires Exact Sciences In $23 Billion Deal - Patch
Abbott Labs stock to acquire Exact Sciences for $21 billion - Investing.com India
Abbott Labs stock gains as UBS reiterates Buy rating on Exact Sciences deal - Investing.com India
Abbott Laboratories’ Strategic Acquisition of Exact Sciences: Enhancing Diagnostics Business and Long-term Growth Prospects - TipRanks
Top 2 Healthcare Stocks Every New Investor Should Know - The Motley Fool
Street View: Brokerages downgrade Exact Sciences following acquisition by Abbott - TradingView
Abbott’s colon-screening deal stinks financially - TradingView
Barclays Sticks to Its Buy Rating for Abbott Laboratories (ABT) - The Globe and Mail
Abbott Breaks into Lucrative Cancer Screening Market with $21 Billion Exact Sciences Purchase - The Daily Upside
Abbott's $21B splurge signals long-awaited dealmaking thaw in health tech - Crain's Chicago Business
Madison's Exact Sciences purchased by Abbott Laboratories, Ancient canoe is the region's oldest - WPR
Abbott to acquire all outstanding shares in Exact Sciences - Medical Device Network
Why Abbott Laboratories (ABL) stock could be next leaderEarnings Beat & Safe Entry Zone Identification - newser.com
Abbott Laboratories’ Strategic Acquisition of Exact Sciences: Enhancing Diagnostics and Driving Long-term Growth - TipRanks
0.61%
0.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):